导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 43.14% | 65/1050 |
| 近一周 | -1.96% | 390/1104 |
| 近一月 | -3.87% | 475/1102 |
| 近一季 | -9.75% | 650/1092 |
| 近半年 | 32.52% | 57/1070 |
| 近一年 | 41.16% | 104/1018 |
| 近两年 | 156.82% | 89/926 |
| 近三年 | 103.06% | 90/834 |
| 成立以来 | 148.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.01% 337/1070 |
101.68% 46/1101 |
- - |
- - |
| 2025 | 52.00% 171/1065 |
19.93% 27/1014 |
5.41% 274/1038 |
32.10% 333/1050 |
-8.98% 857/1065 |
| 2024 | -0.28% 591/1011 |
-13.81% 882/960 |
-4.28% 590/983 |
25.12% 12/991 |
-3.39% 564/1011 |
| 2023 | -7.18% 259/952 |
6.59% 235/880 |
-12.23% 814/895 |
4.44% 4/915 |
-5.00% 502/952 |
| 2022 | -26.80% 549/867 |
-19.28% 477/773 |
1.64% 669/806 |
-16.18% 627/845 |
6.45% 151/867 |
| 2021 | -3.90% 401/740 |
-8.64% 461/580 |
12.34% 301/659 |
-4.94% 352/704 |
-1.51% 494/740 |
| 2020 | 73.92% 124/554 |
1.61% 120/419 |
35.54% 67/466 |
5.67% 352/517 |
19.51% 125/554 |
| 2019 | 48.85% 158/410 |
31.60% 288/1146 |
-3.44% 614/1228 |
9.99% 108/390 |
6.50% 296/410 |
| 2018 | -25.94% 161/349 |
- - |
-3.04% 141/990 |
-11.85% 859/1000 |
-15.67% 898/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 嘉实前沿科技沪港深股票A VS. 东吴新产业精选股票A(580008) |